Qvr LLC Abb Vie Inc. Transaction History

Qvr LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	BUY	$134.21 - $153.93 $1.04 Million - $1.19 Million	7,754 New	7,754 $1.04 Million
Q4 2021 Jan 31, 2022	SELL	$107.43 - $135.93 $386,640 - $489,212	-3,599 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$106.4 - $120.78 $333,351 - $378,403	3,133 Added 672.32%	3,599 $388,000
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $7,995 - $8,907	-76 Reduced 14.02%	466 $52,000
Q4 2020 Jan 29, 2021	BUY	$80.49 - $108.67 $43,625 - $58,899	542 New	542 $58,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Qvr LLC, based on Form 13F filings with the SEC.

Stay updated on Qvr LLC with notifications on news.